Munich-based Alstin Capital secures €175M for new fund; already invested in these startups
Alstin Capital, a Munich-based venture capital firm specialising in early-stage B2B software investments, has raised €175M for its Alstin III fund.
Popular topics
Venture capital — fund formation, deal flow, the institutional incentives that govern where money goes, and the founder relationships that move it.
456 articles · Venture Capital
Alstin Capital, a Munich-based venture capital firm specialising in early-stage B2B software investments, has raised €175M for its Alstin III fund.
Berlin-based EWOR, a radically selective founder fellowship, announced that Petter Made, co-founder of SumUp, and Quinten Selhorst, founder of Felyx, have joined as full-time partners.
Oslo-based Verdane, an investment firm that partners with tech-enabled and sustainable European businesses, has closed its latest sustainable-focused fund, Idun II, at €700M hard cap.
General Catalyst, a global investment and transformation company, has closed its largest fund to date, raising approximately $8B (approximately €7.39B) in new capital.
London-based Resurge Growth Partners has launched a €120M “venture equity” vehicle to bridge the gap between venture capital and private equity for high-potential European and Israeli scaleups.
Stockholm-based Node.vc, a Nordic early-stage venture capital firm, has closed a €71M fund.
Prague-based PurposeTech has closed its first pre-seed venture capital fund to support founders from Central and Eastern Europe (CEE) focused on health, sustainability, and education.
Paris-based Kurma Partners, a venture capital group specialised in healthcare, has announced the first closing of its latest venture capital investment fund, Biofund IV, with a total of €140M raised to date.
Headline, a Europe- and SF-based venture capital firm, announced that it has raised $865M (approximately €776.57M) for its Global Growth IV fund to support companies at their growth inflection points, focusing on Series B and beyond.
Eindhoven-based LUMO Labs, the Dutch fund manager behind impact-driven investment funds in emerging technologies, has appointed Linn-Cecilie Linneman and Jorge Blasco as new team members in Norway and Spain, respectively, ensuring local representation in these strategic regions.
Lund-based SmiLe Inject Capital, part of the SmiLe Venture Hub, is investing SEK 9M (€800K) in three life science startups, including Uman Sense, Nygen Analytics, and Aligned Bio.
Zurich-based Redalpine, a Swiss venture capital firm that empowers “GameChangers”, has secured its largest fund to date, the oversubscribed $200M (approximately €179M) Redalpine Capital VII (RAC VII).